|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Peripheral Artery Disease | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Peripheral Vascular Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| lovaza | |||||
| placebo | |||||
| 5 | Sponsors listed in this trial | ||||
| University of Virginia | |||||
| Reliant Pharmaceuticals | |||||